The purpose of this study is to determine the feasibility, safety, and efficacy of revision gastroplasty along with other adjunct procedures in the treatment of intractable / chronic marginal ulcers after Roux-en-Y gastric bypass. A secondary aim is the identification of good and poor outcome predictors after revisional strategies for intractable or chronic marginal ulcer.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Morbidity and mortality
Timeframe: at discharge, 1 week, 3 weeks, 8 weeks, 3 months, 6 months, 1 year and annually thereafter for up to 4 years
Weight loss expressed as Body Mass Index and Percentage excess weight loss
Timeframe: at 6 months, 1 year and annually thereafter for up to 4 years
Remission or improvement of marginal ulcer-related symptoms
Timeframe: at 6 months, 1 year and annually thereafter for up to 4 years
Remission or improvement of comorbidities
Timeframe: at 6 months, 1 year and annually thereafter for up to 4 years